Dr. Larry Lynd, professor and director of the Collaboration for Outcomes Research and Evaluation (CORE) at the University of British Columbia (UBC) Faculty of Pharmaceutical Sciences, was named a Fellow of the Canadian Academy of Health Sciences (CAHS) on September 13, 2018.
Dr. Lynd was honoured together with other 2018 CAHS Fellows at an induction ceremony held at the Marriott Pinnacle Downtown Hotel in Vancouver, B.C.
Induction into CAHS is regarded as a prominent honour in the Canadian academic community. CAHS Fellows serve as unpaid volunteers, evaluating and recommending solutions for Canada’s most complex health challenges based on their respective areas of healthcare and research expertise. Nominations are judged in a competitive process based on criteria in the areas of international leadership, academic performance, scientific creativity, and willingness to serve.
Dr. Lynd received his BSP in 1986 from the University of Saskatchewan and his PhD in the Department of Health Care and Epidemiology at UBC in 2002. He then completed a two-year post-doctoral fellowship in health economics with Dr. Bernie O’Brien at McMaster University. In addition to his roles as professor and director of CORE, he is scientist at the Centre for Health Evaluation and Outcomes Sciences and the Centre for Clinical Epidemiology and Evaluation, scholar at the Peter Wall Institute of Advanced Studies, and associate of the UBC School of Population and Public Health.
Throughout his career, Dr. Lynd has made significant contributions serving on a number of committees, including chair of the Health Canada Special Advisory Committee on Non-Prescription Drugs, Special Advisory Committee to the Respiratory and Allergy Therapies Division of Health Canada, BC Ministry of Health Services Expensive Drugs for Rare Diseases Committee, and the BC PharmaNet Data Stewardship Committee. His primary areas of scholarly interest include epidemiology and health economics, working specifically in respiratory medicine, orphan drugs and rare diseases, multiple sclerosis, and genomic medicine, and internationally in Rwanda and Cambodia.
“I am very honoured to be inducted into the Canadian Academy of Health Sciences, and I have to thank the outstanding mentors I have had throughout my career for their support and guidance in my academic journey,” says Dr. Lynd. “As a CAHS Fellow, together with my colleagues, I am committed to continuing to advance healthcare research and mentoring our future academic leaders for the benefit of all Canadians.”
